AMD vs. Broadcom: The Better AI-Chip Stock to Buy After the Sell-Off

The market is treating AI semis as one crowded factor trade, so the immediate issue is not who has the better product narrative but who can defend the valuation when multiples compress. Broadcom looks better insulated because cash conversion and dividends reduce downside in a risk-off tape; AMD’s cleaner operating leverage cuts both ways, but it also leaves the stock more exposed if the next product cycle slips by even one quarter.

Second-order, the real debate is customer concentration versus ecosystem optionality. Broadcom’s custom accelerators tie directly to a few hyperscalers, which creates lumpiness but also makes its order book harder to dislodge once designs are in production; AMD is more dependent on proving that its next accelerator family can turn pipeline into durable share, not just headline enthusiasm. In a 1-3 month window, the key catalyst is whether cloud capex updates confirm AI spending acceleration; if they don’t, AMD’s richer multiple is the first to mean-revert.

Contrarianly, the selloff may be underpricing the fact that not all AI exposure is equal: the market is rewarding recurring free cash flow more than pure growth now. That favors AVGO over AMD in a risk-adjusted sense, but it also means AVGO’s relative outperformance could stall if the market starts discounting custom-chip concentration or if one large customer delays deployment. Over 6-18 months, AMD remains the higher-beta upside call, but only if MI450 ramps through expectations instead of merely meeting them.